论文部分内容阅读
目的:分析促肝细胞生长素及相关药物与血磁疗联合治疗对病毒性肝炎患者的疗效。方法:选择病毒性肝炎住院患者91例,随机分为联合治疗组和对照组。联合治疗组48例采用促肝细胞生长素、其它有关药物与血磁疗进行综合治疗;对照组43例不用血磁疗,其它治疗与联合治疗组相同。同时检测ALT、TBIL、HBsA2、HBeAg。结果:联合治疗组与对照组肝功能复常、退黄时间及HBsAg、HBeAg转阴有显著差异。结论:联合治疗组的治疗效果明显强于对照组。
Objective: To analyze the effect of hepatocyte growth-promoting hormone and related drugs and blood magnetic therapy on patients with viral hepatitis. Methods: Ninety-one inpatients with viral hepatitis were randomly divided into combined treatment group and control group. In the combined treatment group, 48 cases were treated with hepatocyte growth-promoting hormone, other related drugs and blood magnetic therapy. In the control group, 43 cases did not use blood magnetic therapy, and the other treatments were the same as the combination treatment group. Simultaneous detection of ALT, TBIL, HBsA2, HBeAg. Results: There was a significant difference between the combined treatment group and the control group in the recovery of liver function, the time of rehospitalization and the negative conversion rate of HBsAg and HBeAg. Conclusion: The treatment effect of combined treatment group is obviously stronger than that of control group.